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IDIOPATHIC HYPERCALCAEMIA (IHC) 
Introduction: IHC is a syndrome in cats with abnormally high blood total (tCa) 
and/or ionised calcium (iCa) for which all published causes of persistent 
hypercalcaemia have been eliminated following extensive investigations and long-
term follow up. These causes include chronic kidney disease (CKD), neoplasia 
(lymphoma, squamous cell carcinoma, bronchogenic carcinoma, multiple 
myeloma, osteosarcoma, fibrosarcoma), primary hyperparathyroidism (rare), 
hypervitaminosis D (plants, rodenticide, antipsoriasis cream), chronic 
granulomatous disease and hypoadrenocorticism (very rare). The extensive 
investigations include haematology, biochemistry, urinalysis, endocrinological 
testing (PTH, 25-hydroxyvitamin D, calcitriol, PTHrp) and diagnostic imaging.    
Clinical and clinico-pathological findings: Up to half of cats with IHC have no 
clinical signs (especially in the early stages of the disease) and ionised 
hypercalcaemia often is detected during routine laboratory testing for health 
check-ups and pre-anaesthetic screenings. Cats of all ages may be affected and 
there is no sex predisposition. In symptomatic cats clinical signs include mild 
weight loss, lethargy, anorexia, vomiting, diarrhoea and constipation. Pollakiuria, 
stranguria and haematuria are seen if urolithiasis is also present. 
In most cases the tCa is around 3 mmol/l (not higher than 3.6mmol/l), iCa 
between 1.4 and 1.9 mmol/l and serum phosphorus within normal limits (unless 
concurrent CKD is present). In most cats, PTH concentrations are within the 
reference interval (often lower end), the PTHrP is undetectable while the ionized 
magnesium, 25-hydroxyvitamin D and calcitriol concentrations are usually within 
normal limits.  
Measurement of tCa and iCa: In cats, measurement of tCa cannot be reliably used 
to predict the concentration of the metabolically active iCa. It has been shown that 
only 30% of cats with ionised hypercalcaemia also have increased tCa 
concentrations. For this reason screening cats for calcium metabolic disorders is 
better served by the measurement of iCa. Large fluctuations in tCa and iCa 
concentrations can be observed in some cats with IHC. In addition, it has been 
reported that iCa concentrations can fluctuate into and above the reference 
interval, especially when the hypercalcemia is marginal in magnitude.  
Ionized calcium and tCa concentrations can be measured using in-house hand-
held or bench-top analysers or by external laboratories (special requirements for 
measuring iCa in postal samples). Serum or heparinised plasma samples can be 
used for tCa measurement but for iCa, ideally, a sample should be collected 
anaerobically. Exposure to air and loss of CO2 can result in a more alkaline pH of 
blood or serum promoting more calcium binding to albumin and subsequently 
lower iCa concentrations. Whole blood or heparinised plasma are also acceptable 
samples for analysis of iCa although pH and iCa are more stable in serum.  
Treatment: It has been suggested that multiple underlying causes or 
pathomechanisms (e.g. genetic predispositions, epigenetic changes altering 
calcium metabolism and hormonal control) will be discovered for feline IHC. 
However, as at present the pathogenesis of IHC is unknown and there is no 
specific treatment. It is controversial, if asymptomatic cats with mild ionised 
hypercalcaemia should be treated. Even so, treatment should start when iCa 
continues to increase and/or clinical signs become obvious. Dietary modification 
(wet rather than dry diets, high-fibre diets, renal diets, diets developed to prevent 
calcium oxalate urolithiasis), treatment with bisphosphonates (e.g. alendronate) or 
prednisolone can be considered.  
 
IDIOPATHIC HYPOKALAEMIA  
Introduction: Over 90% of the potassium in the body is located within cells. 
Hypokalaemia implies either normal total body potassium but with a transient 
translocation of potassium from the extracellular to the intracellular space or 
depletion of the total body potassium. Hypokalaemia in cats is most commonly 
due to: 
 a) potassium translocation from extracellular into intracellular fluid spaces 
resulting from alkalaemia, administration of insulin or glucose containing fluids 
(including those without potassium) and profound catecholamine release  
b) increased potassium loss via the kidneys, particularly associated with diuresis 
or via the gastrointestinal tract, particularly resulting from vomiting (especially of 
stomach contents) or diarrhoea. Loss is exacerbated in cats fed potassium 
deficient diets containing urinary acidifiers.  
The most common diseases associated with hypokalaemia in cats are chronic 
renal failure, systemic viral or bacterial infections, gastrointestinal disease, 
neuromuscular/CNS disease and hepatic disease. 
Periodic hypokalaemic polymyopthy: This syndrome develops in cats 2-10 
months of age and is characterised by recurrent episodes of limb muscle 
weakness, head and neck ventroflexion, increased serum CK, AST and ALT 
activities and hypokalaemia (K+ < 3.0 or 2.5 mmol/l according to some experts). 
This disease was first reported in 1983 and since then all cases have been 
observed mainly in Burmese and Tonkinese cats although there is a strong 
possibility for the problem to develop in breeds that have been based on Burmese 
outcrossings (e.g. Burmilla). For almost 30 years this syndrome was considered an 
example of idiopathic hypokalaemia until 2012 when it was shown that this 
disease is a very specific potassium wasting nephropathy which is caused by a 
mutation in the gene coding for the enzyme lysine-deficient 4 protein kinase 
(WNK4). This enzyme regulates complex pathways that collectively control 
sodium and potassium transportation. Ultimately, this mutation alters the function 
of WNK4 somehow causing sufficient urinary loss of potassium to result in 
symptomatic hypokalaemia. 
Diagnosis and treatment: A PCR test on an EDTA blood sample or cheek swab is 
used to test for the mutation. In suspect cases, the test can diagnose this inherited 
hypokalaemia even in cats with normal serum potassium concentration. In 
addition, the test can identify the cats that are heterozygous for the defective gene 
(i.e., are carriers). Enteric-coated sustained-release potassium chloride tablets with 
food are used to manage Burmese cats with hypokalaemia. 
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